Online citations, reference lists, and bibliographies.
← Back to Search

Nanoplatforms Of Manganese Ferrite Nanoparticles Functionalized With Anti‐Inflammatory Drugs

K. Giannousi, Emmanouil Koutroumpis, Violetta Georgiadou, Vasilis Karagkounis, C. Dendrinou-Samara
Published 2019 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/j.jinorgbio.2016.09.003
Synthesis and biological evaluation of PEGylated CuO nanoparticles.
K. Giannousi (2016)
10.1016/0378-5173(89)90306-2
A simple equation for the description of solute release. III. Coupling of diffusion and relaxation
N. Peppas (1989)
10.1021/CR60108A003
The Chemistry of Protein Denaturation.
H. Neurath (1944)
10.1021/ACS.JPCC.5B00717
Unveiling the Physicochemical Features of CoFe2O4 Nanoparticles Synthesized via a Variant Hydrothermal Method: NMR Relaxometric Properties
Violetta Georgiadou (2015)
10.1038/s41598-018-23317-2
Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles
Anirudh Sharma (2018)
10.1021/CM0628000
Silane Ligand Exchange to Make Hydrophobic Superparamagnetic Nanoparticles Water-Dispersible
R. D. Palma (2007)
10.1016/j.msec.2018.09.059
Mononuclear copper(II) complexes with 2-thiophene carboxylate and N-N donors; DNA interaction, antioxidant/anti-inflammatory and antitumor activity.
Z. Boulsourani (2019)
Impact of the Presence of Octadecylamine on the Properties of Hydrothermally Prepared CoFe2O4Nanoparticles: Properties of CoFe2O4Nanoparticles
Violetta Georgiadou (2014)
10.2217/nnm-2016-0341
Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases.
I. ElSherbiny (2017)
10.4049/jimmunol.0900477
Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans1
Thea Morris (2009)
10.1136/ard.62.6.501
Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs
J. Martel-Pelletier (2003)
10.1021/acs.langmuir.5b03947
Origin of the Instability of Octadecylamine Langmuir Monolayer at Low pH.
Zaure Avazbaeva (2015)
10.1016/j.addr.2009.11.002
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
O. Veiseh (2010)
10.3923/AJDD.2012.143.183
A Review on Novel Therapeutic Strategies for the Enhancement of Solubility for Hydrophobic Drugs through Lipid and Surfactant Based Self Micro Emulsifying Drug Delivery System: A Novel Approach
S. Agrawal (2012)
10.1080/00958972.2011.654203
Spectroscopic, thermal analysis, and antimicrobial evaluation of new Y(III), Zr(IV), and U(VI) ibuprofen complexes
W. A. Zordok (2012)
10.1039/c4dt00162a
Reducing the inversion degree of MnFe2O4 nanoparticles through synthesis to enhance magnetization: evaluation of their (1)H NMR relaxation and heating efficiency.
K. Vamvakidis (2014)
10.1007/s10787-011-0099-z
Dissolution and pharmacokinetics of a novel micronized aspirin formulation
M. Voelker (2011)
10.3797/scipharm.ISP.2015.09
Dissolution Profile of Mefenamic Acid Solid Dosage Forms in Two Compendial and Biorelevant (FaSSIF) Media
Wilda Nurhikmah (2016)
10.1016/0168-3659(87)90034-4
A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs
P. L. Ritger (1987)
10.1021/acsami.5b01786
Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment.
S. Patra (2015)
10.1021/acs.chemrev.5b00589
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies.
K. Ulbrich (2016)
10.1039/B506241A
Practical control of SERRS enhancement.
D. Cunningham (2006)
10.1016/J.APSUSC.2017.09.096
Synthesis and characterization of polymer-coated manganese ferrite nanoparticles as controlled drug delivery
G. Wang (2018)
10.1016/0168-3659(87)90035-6
A simple equation for description of solute release II. Fickian and anomalous release from swellable devices
P. L. Ritger (1987)
10.1021/nn900002m
Impact of nanotechnology on drug delivery.
O. Farokhzad (2009)
10.1007/s11051-013-1874-0
Effect of surface charge on the colloidal stability and in vitro uptake of carboxymethyl dextran-coated iron oxide nanoparticles
V. Ayala (2013)
10.1002/advs.201700513
Polysaccharide‐Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside
Tianxin Miao (2018)
10.1038/s41467-018-03705-y
Progress and challenges towards targeted delivery of cancer therapeutics
D. Rosenblum (2018)
10.1038/nbt.3330
Principles of nanoparticle design for overcoming biological barriers to drug delivery
E. Blanco (2015)
10.1021/la2022177
Preparation of peptide-functionalized gold nanoparticles using one pot EDC/sulfo-NHS coupling.
D. Bartczak (2011)
10.1007/s11051-013-1743-x
Size and compositionally controlled manganese ferrite nanoparticles with enhanced magnetization
K. Vamvakidis (2013)
10.1039/c5cp00831j
Nanosystems: the use of nanoalloys, metallic, bimetallic, and magnetic nanoparticles in biomedical applications.
K. McNamara (2015)
10.2147/IJN.S141201
Synthesized zinc peroxide nanoparticles (ZnO2-NPs): a novel antimicrobial, anti-elastase, anti-keratinase, and anti-inflammatory approach toward polymicrobial burn wounds
S. Ali (2017)
10.1039/c3cs60273g
Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy.
V. Biju (2014)
10.1039/B820176E
A novel core-shell structured magnetic organic-inorganic nanohybrid involving drug-intercalated layered double hydroxides coated on a magnesium ferrite core for magnetically controlled drug release
Hui Bin Zhang (2009)
10.1002/asia.201301590
Preparation of monodisperse ferrite nanocrystals with tunable morphology and magnetic properties.
Ruizheng Liang (2014)
10.1039/C5TB00734H
Hetero-nanocomposites of magnetic and antifungal nanoparticles as a platform for magnetomechanical stress induction in Saccharomyces cerevisiae.
K. Giannousi (2015)
10.11648/J.JDDMC.20170306.11
Naproxen-Gelucire Nanoformulations for Improved Solubility and Dissolution Rate of Poorly Water-Soluble Drug Naproxen
S. Patnaik (2017)
10.1021/acsami.6b00408
Octadecylamine-Mediated Versatile Coating of CoFe2O4 NPs for the Sustained Release of Anti-Inflammatory Drug Naproxen and in Vivo Target Selectivity.
Violetta Georgiadou (2016)
10.5958/0974-360X.2015.00134.1
Determination of Saturated Solubility of Naproxen using UV Visible Spectrophotometer
L. Kumar (2015)
10.1111/j.1471-4159.2004.02743.x
Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action
L. Gasparini (2004)
10.1016/j.addr.2012.04.010
Nanoparticles in drug delivery: past, present and future.
P. Couvreur (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar